Selank and semax as potential hepatoprotectors in medical treatment of tuberculosis
Introduction: Drug-induced hepatitis is common in clinical practice. This problem is particularly relevant in the treatment of tuberculous infection, because for this purpose, up to 5-6 hepatotoxic drugs are used simultaneously for a long time, which often (in 15-20% of cases) leads to medical liver...
Saved in:
Main Authors: | Alexey K. Petrovsky (Author), Nikolay A. Smirnov (Author), Vladimir P. Vdovichenko (Author), Tatiana B. Fedorova (Author), Edgar E. Kerbenev (Author), Vladimir N. Fedorov (Author) |
---|---|
Format: | Book |
Published: |
Belgorod National Research University,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The experimental study of the immunomodulating action of Semax and Selank on the model of "social" stress
by: Yasenyavskaya A.L, et al.
Published: (2022) -
Treatment of hepatitis induced by anti-tuberculosis drugs (experimental research)
by: Vladimir N. Fedorov, et al.
Published: (2020) -
Structural transformations of thermal burn wounds in rats under the influence of Semax and Selank neuropeptides
by: A. K. Azhikova, et al.
Published: (2020) -
Selank Administration Affects the Expression of Some Genes Involved in GABAergic neurotransmission
by: Anastasiya eVolkova, et al.
Published: (2016) -
Screening of Phytochemical Secondary Metabolites of Muntingia Calabura: a Potential as Hepatoprotector
by: Elasari Dwi Pratiwi, et al.
Published: (2022)